HEARTS Act of 2022

• Authority: United States Congress
• Parent authority: Federal government
• Jurisdiction: United States
• Collections: U.S. federal laws
• Most recent activity: Defunct
• Most recent activity date: 2025-01-03

Risk subdomain coverage

Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the risk subdomain are described.

• Lack of capability or robustness

All other risk subdomains had no coverage in this document.

Risk Coverage Summary

The document has minimal coverage of AI risk domains, with only subdomain 7.3 (Lack of robustness) receiving a coverage score of 2. The document primarily addresses animal research alternatives and mentions AI as one of several innovative nonanimal research methods. It does not substantively address AI-specific risks, harms, or governance challenges.

Sector coverage

Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.

• Scientific Research & Development Services
• Public Administration (excl. National Security)

Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.

• Educational Services
• Health Care & Social Assistance

All other sectors had no coverage in this document.

Sectors Summary

The document primarily governs the Scientific Research and Development Services sector, specifically biomedical research conducted or funded by the National Institutes of Health. It also has implications for Health Care and Social Assistance through its impact on medical research practices.

Legislative Status

Hard Law

Legislative Status Summary

This is a binding federal statute enacted by the United States Congress with mandatory obligations, enforcement mechanisms, and legal penalties for non-compliance.

Actors

Proposer

• Entity Types: AI_Governance_Actor
• Entities: United States Congress; Mr. Pappas; Mr. Calvert; House Committee on Energy and Commerce
• Summary: The document is a bill introduced in the U.S. House of Representatives by Representatives Pappas and Calvert, referred to the Committee on Energy and Commerce. Congress is the proposing authority for this federal legislation.

Target

• Entity Types: AI_Governance_Actor
• Entities: National Institutes of Health (NIH); federally funded researchers; covered reporting entities; Federal departments or agencies that use animals in research or testing
• Summary: The Act targets NIH-supported research, federally funded researchers, and any entity receiving federal funds for research or testing. It establishes obligations for research institutions and federal agencies conducting animal research.

Enforcer

• Entity Types: AI_Governance_Actor
• Entities: Secretary of Health and Human Services; National Institutes of Health (NIH); National Center for Alternatives to Animals in Research and Testing; Director of the National Center
• Summary: The Secretary is responsible for establishing the National Center, which has enforcement authority through funding decisions, research proposal review requirements, and monitoring compliance with reporting obligations.

Monitor

• Entity Types: AI_Governance_Actor
• Entities: National Center for Alternatives to Animals in Research and Testing; Director of the National Center
• Summary: The National Center is explicitly tasked with collecting information on animal use in federally funded research, receiving reports from covered entities, and making this information publicly available. The Center monitors compliance through biennial reporting requirements.

AI Lifecycle Stages

Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems

No lifecycle stages identified.

AI Lifecycle Summary

The document does not substantively govern AI lifecycle stages. AI is mentioned only as one example among many nonanimal research methods (alongside organoids, stem cells, 3D modeling, etc.). The document focuses on animal research alternatives broadly, not AI development or deployment specifically.

Technical Scope

Terms relating to technical scope that are mentioned or implicitly referenced in the document

No technical scope terms identified.

Technical Scope Summary

The document mentions artificial intelligence only once as one example among many nonanimal research methods. It does not define AI, discuss AI models or systems, or address any specific AI technical categories. The focus is on biomedical research alternatives to animal testing, not AI governance.